These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2536638)

  • 1. Immunization with syngeneic Sendai virus-infected cells induce no MHC-restricted antibodies but antibodies specific for H-2 class I determinants.
    Kievits F; Boerenkamp WJ; Ivanyi P
    Immunogenetics; 1989; 29(2):108-11. PubMed ID: 2536638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of anti-H-2 class I antibodies induced by syngeneic immunization with Sendai virus-treated cells is regulated by the mouse MHC and viral antigens. No evidence for MHC-restricted virus-specific antibodies.
    Kievits F; van Bleek GM; Boerenkamp WJ; Pla M; Ivanyi P
    J Immunogenet; 1989 Feb; 16(1):3-17. PubMed ID: 2550555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of H-2-specific antibodies by injections of syngeneic Sendai virus-coated cells.
    Kievits F; Rocca A; Opolski A; Limpens J; Leupers T; Kloosterman T; Boerenkamp WJ; Pla M; Ivanyi P
    Eur J Immunol; 1987 Jan; 17(1):27-35. PubMed ID: 3028822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies.
    Froscher BG; Klinman NR
    J Exp Med; 1986 Jul; 164(1):196-210. PubMed ID: 3014034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-major histocompatibility complex immunity detected prior to intentional alloimmunization. I. Naturally occurring H-2-specific antibodies in C57BL/KaLwRij (H-2b) mice.
    Cerný-Provaznik R; Radl J; van Mourik P; Leupers T; Brondijk R; de Greeve P; Iványi P
    Nat Immun Cell Growth Regul; 1985; 4(3):138-59. PubMed ID: 3876506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells.
    Kast WM; de Waal LP; Melief CJ
    J Exp Med; 1984 Dec; 160(6):1752-66. PubMed ID: 6096476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of virus specific cytotoxic T cells in vitro. III. Spleen cells stimulated by viral antigens generate alloreactive cytotoxic T cells.
    Koszinowski U; Greber D; Neuschaefer-Rube I
    Immunobiology; 1979 Aug; 156(1-2):83-95. PubMed ID: 232074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-H-2 antibodies induced by syngeneic immunization.
    Iványi P; van Mourik P; Breuning M; Melief CJ
    Immunogenetics; 1980; 10(4):319-32. PubMed ID: 22457924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency analysis of cytotoxic T lymphocyte precursors in chimeric mice. Evidence for intrathymic maturation of clonally distinct self-major histocompatibility complex- and allo-major histocompatiblilty complex-restricted virus-specific T cells.
    Wagner H; Hardt C; Bartlett R; Stockinger H; Röllinghoff M; Rodt H; Pfizenmaier K
    J Exp Med; 1981 Jun; 153(6):1517-32. PubMed ID: 6265587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex-restricted self-recognition in responses to trinitrophenyl-ficoll. Adaptive differentiation and self-recognition by B cells.
    Singer A; Hodes RJ
    J Exp Med; 1982 Nov; 156(5):1415-34. PubMed ID: 6982306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells.
    Wylie DE; Sherman LA; Klinman NR
    J Exp Med; 1982 Feb; 155(2):403-14. PubMed ID: 6173456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
    Sakita I; Hörig H; Sun R; Wang F; Nathenson SG
    J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the possibility of induction of anti-H-2 alloreactive cytotoxic antibodies by syngeneic immunization.
    Opolski A; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):621-30. PubMed ID: 6085470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.
    Donda A; Cesson V; Mach JP; Corradin G; Primus FJ; Robert B
    Cancer Immun; 2003 Aug; 3():11. PubMed ID: 12916958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL.
    Lee K; Takenaka H; Yoneda Y; Goto T; Sano K; Nakanishi M; Eguchi A; Okada M; Tashiro J; Sakurai K; Kubota T; Yoshida R
    Microbiol Immunol; 2004; 48(1):15-25. PubMed ID: 14734854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.